395 related articles for article (PubMed ID: 25422264)
21. Quantitative evaluation of tissue invasion by wild type, hyphal and SAP mutants of Candida albicans, and non-albicans Candida species in reconstituted human oral epithelium.
Jayatilake JA; Samaranayake YH; Cheung LK; Samaranayake LP
J Oral Pathol Med; 2006 Sep; 35(8):484-91. PubMed ID: 16918600
[TBL] [Abstract][Full Text] [Related]
22. Morphogenesis is not required for Candida albicans-Staphylococcus aureus intra-abdominal infection-mediated dissemination and lethal sepsis.
Nash EE; Peters BM; Palmer GE; Fidel PL; Noverr MC
Infect Immun; 2014 Aug; 82(8):3426-35. PubMed ID: 24891104
[TBL] [Abstract][Full Text] [Related]
23. Perspective on receptor-associated immune response to Candida albicans single and mixed infections: Implications for therapeutics in oropharyngeal candidiasis.
Yang L; Cheng T; Shao J
Med Mycol; 2023 Aug; 61(8):. PubMed ID: 37533203
[TBL] [Abstract][Full Text] [Related]
24. T cells specific for Candida albicans antigens and producing type 2 cytokines in lesional mucosa of untreated HIV-infected patients with pseudomembranous oropharyngeal candidiasis.
Vultaggio A; Lombardelli L; Giudizi MG; Biagiotti R; Mazzinghi B; Scaletti C; Mazzetti M; Livi C; Leoncini F; Romagnani S; Maggi E; Piccinni MP
Microbes Infect; 2008 Feb; 10(2):166-74. PubMed ID: 18249024
[TBL] [Abstract][Full Text] [Related]
25. Candida albicans VPS4 contributes differentially to epithelial and mucosal pathogenesis.
Rane HS; Hardison S; Botelho C; Bernardo SM; Wormley F; Lee SA
Virulence; 2014; 5(8):810-8. PubMed ID: 25483774
[TBL] [Abstract][Full Text] [Related]
26. Adhesion of
Van Dyck K; Viela F; Mathelié-Guinlet M; Demuyser L; Hauben E; Jabra-Rizk MA; Vande Velde G; Dufrêne YF; Krom BP; Van Dijck P
Front Cell Infect Microbiol; 2020; 10():624839. PubMed ID: 33604309
[TBL] [Abstract][Full Text] [Related]
27. Staphylococcus-Candida Interaction Models: Antibiotic Resistance Testing and Host Interactions.
Scheres N; Krom BP
Methods Mol Biol; 2016; 1356():153-61. PubMed ID: 26519071
[TBL] [Abstract][Full Text] [Related]
28. Essential role of the Candida albicans transglutaminase substrate, hyphal wall protein 1, in lethal oroesophageal candidiasis in immunodeficient mice.
Sundstrom P; Balish E; Allen CM
J Infect Dis; 2002 Feb; 185(4):521-30. PubMed ID: 11865405
[TBL] [Abstract][Full Text] [Related]
29. N-acetylglucosamine increases symptoms and fungal burden in a murine model of oral candidiasis.
Ishijima SA; Hayama K; Takahashi M; Holmes AR; Cannon RD; Abe S
Med Mycol; 2012 Apr; 50(3):252-8. PubMed ID: 21859389
[TBL] [Abstract][Full Text] [Related]
30. Experimental Models of C. albicans-Streptococcal Co-infection.
Sobue T; Diaz P; Xu H; Bertolini M; Dongari-Bagtzoglou A
Methods Mol Biol; 2016; 1356():137-52. PubMed ID: 26519070
[TBL] [Abstract][Full Text] [Related]
31.
Sheehan G; Tully L; Kavanagh KA
Microbiology (Reading); 2020 Apr; 166(4):375-385. PubMed ID: 32068530
[TBL] [Abstract][Full Text] [Related]
32. Development and In Vivo Evaluation of a Novel Histatin-5 Bioadhesive Hydrogel Formulation against Oral Candidiasis.
Kong EF; Tsui C; Boyce H; Ibrahim A; Hoag SW; Karlsson AJ; Meiller TF; Jabra-Rizk MA
Antimicrob Agents Chemother; 2016 Feb; 60(2):881-9. PubMed ID: 26596951
[TBL] [Abstract][Full Text] [Related]
33. Candida glabrata Binding to Candida albicans Hyphae Enables Its Development in Oropharyngeal Candidiasis.
Tati S; Davidow P; McCall A; Hwang-Wong E; Rojas IG; Cormack B; Edgerton M
PLoS Pathog; 2016 Mar; 12(3):e1005522. PubMed ID: 27029023
[TBL] [Abstract][Full Text] [Related]
34. Invasion process of Candida albicans to tongue surface in early stages of experimental murine oral candidiasis.
Hisajima T; Ishibashi H; Yamada T; Nishiyama Y; Yamaguchi H; Funakoshi K; Abe S
Med Mycol; 2008 Nov; 46(7):697-704. PubMed ID: 18608936
[TBL] [Abstract][Full Text] [Related]
35. Regulation of Candida albicans morphogenesis by tumor necrosis factor-alpha and potential for treatment of oral candidiasis.
Ohta H; Tanimoto T; Taniai M; Taniguchi M; Ariyasu T; Arai S; Ohta T; Fukuda S
In Vivo; 2007; 21(1):25-32. PubMed ID: 17354610
[TBL] [Abstract][Full Text] [Related]
36. Langerin+ DCs regulate innate IL-17 production in the oral mucosa during Candida albicans-mediated infection.
Sparber F; Dolowschiak T; Mertens S; Lauener L; Clausen BE; Joller N; Stoitzner P; Tussiwand R; LeibundGut-Landmann S
PLoS Pathog; 2018 May; 14(5):e1007069. PubMed ID: 29782555
[TBL] [Abstract][Full Text] [Related]
37. Metabolic Adaptations During
Eichelberger KR; Cassat JE
Front Immunol; 2021; 12():797550. PubMed ID: 34956233
[TBL] [Abstract][Full Text] [Related]
38. IL-1alpha, IL-1ra and IL-8 are differentially induced by Candida in experimental oral candidiasis.
Jayatilake JA; Samaranayake LP; Lu Q; Jin LJ
Oral Dis; 2007 Jul; 13(4):426-33. PubMed ID: 17577331
[TBL] [Abstract][Full Text] [Related]
39. Protective effects of human saliva on experimental murine oral candidiasis.
Kamagata-Kiyoura Y; Abe S; Yamaguchi H; Nitta T
J Infect Chemother; 2004 Aug; 10(4):253-5. PubMed ID: 15365870
[TBL] [Abstract][Full Text] [Related]
40. Persistence of
Kirchner FR; Littringer K; Altmeier S; Tran VDT; Schönherr F; Lemberg C; Pagni M; Sanglard D; Joller N; LeibundGut-Landmann S
Front Immunol; 2019; 10():330. PubMed ID: 30873177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]